Published online January 21, 2026
Additionally, eryptosis triggered by nanoscale materials can be associated with caspase-3 activation [452, 454] and calpain involvement [453, 458]
Of particular significance, three large-scale meta-analyses examining the relationship between metformin and prostate cancer risk demonstrated that while metformin significantly improved the prognosis of prostate cancer patients, its use showed no significant association with prostate cancer incidence
(The FDA is expediting review of one such drug, survodutide, for liver-disease patients.) Meanwhile, GLP-1-based drugs appear to protect against cardiovascular disease, even independent of weight loss
The intricacy of creating multi-target medications, carrying out extensive clinical trials, and guaranteeing long-term safety considerably raises total R&D costs